PCI BIOTECH HOLDING ASA: årsregnskap 2009 vs 2008
Grew 17% on revenue, weaker earnings, cash halved-plus
approved 2010-04-27; registry 2010-05-15
Summary
What changed
Comparing Årsregnskap 2009 with 2008 for PCI BIOTECH HOLDING ASA. Revenue 7.37m NOK → 8.61m NOK (+16.9%). Net result -11.38m NOK → -15.02m NOK.
On the constructive side: revenue rose. Pressures included: operating result weakened; net result weakened; cash fell.
Also worth watching: sharp cash drawdown; paid-in equity reduced; book investments changed. All figures are taken from the published annual accounts for PCI BIOTECH HOLDING ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 7.37m NOK to 8.61m NOK (+16.9% YoY). Calculated
What deteriorated
-
↓
Operating result weakened
Operating result -12.14m NOK → -17.69m NOK (op. margin -164.8% → -205.4%). Calculated
-
↓
Net result weakened
Net result -11.38m NOK → -15.02m NOK (net margin -154.4% → -174.3%). Calculated
-
↓
Cash fell
Bank deposits 49.31m NOK → 6.48m NOK (-86.9% YoY). Calculated
Things to notice
-
·
Sharp cash drawdown
Cash fell by more than 60% YoY (49.31m NOK → 6.48m NOK). Check whether funds moved to group receivables, investments, or operating burn. Interpretation
-
·
Paid-in equity reduced
Paid-in equity fell 104.70m NOK → 16.11m NOK — check capital reduction, conversion, or reclassification. Interpretation
-
·
Book investments changed
Investment / intangible book value 6.00m NOK → 41.00m NOK. Reported fact